Lipid Disorder Treatment Market By Product Type ( Atorvastatin, Fluvastatin, Rosuvastatin, Simvastatin, Pravastatin ), By Distribution Channe ( Retail Pharmacies, Hospital Pharmacies, Online Pharmacies ), By Indication ( Familial Combined Hyperlipidemia, Familial Defective Apolipoprotein B-100, Familial Dysbetalipoproteinemia, Familial Hypertriglyceridemia, Heterozygous Familial Hypercholesterolemia ), Industry Trends, Estimation & Forecast, 2017 - 2025

May 2018

 Pages: 196

 ERC 7478


Lipid Disorder Treatment Market is expected to grow with a CAGR of xx% during the forecast period of 2018 to 2025.

Lipids are one of the major components of the body which are made up of hydrocarbons and are extensively important in the formation and functioning of living cells. They are fat like substances and reside in the form of oils, waxes and vitamins within the body. In the common term, lipids are also called as cholesterol. Lipids play a major role in the proper functioning of the body, especially the cardiovascular system, but, can be equally dangerous if not balanced in a certain ratio. Lipid disorder is one of the fastest emerging health issue in the world, among all age groups; from children to adults. The presence of improper amount of LDL-Cholestrol and Tryglycerides in the blood stream is the major cause of lipid related health problems. The excessive amount of bad-cholestrol can lead to cardiovascular issues such as atherosclerosis, internal blood clots, estrogen drop, loss of memory, gall stones, fatigue and even fatal heart attacks. As per WHO, nearly one-third of all the ischaemic heart diseases are caused as a result of high cholesterol. A constant rise in the occurrence of cardio-vascular diseases is the major factor which is propelling the demand for lipid disorder treatment or therapies all over the world. Moreover, changing trends, sedentary lifestyle, improper food habits and constantly increasing obesity are the major causes which are leading to the generation of lipid disorders, especially among the people under the age-group of (40-60) years. As per the Centers of Disease Control and Prevention, nearly 71 million Americans have high low-density lipoprotein (LDL). Constantly increasing awareness and government initiatives such as seminars and health checkup camps might stimulate the global lipid disorder treatment market growth in the near future.

The report provides detailed qualitative and quantitative analysis of the Lipid Disorder Treatment Market. Market size and forecast in terms of value and volume has been provided for the period - (2017 - 2025), for the segments namely type and application in each of the major regions.

Lipid Disorder Treatment Market Player Analysis -

The report presents detailed analysis of major players operating in Lipid Disorder Treatment Market. Few of the include Pfizer, Inc., Novartis AG, Astrazeneca Plc., Merck & Co., Emcure Pharmaceuticals Ltd., Ranbaxy Laboratories Ltd., Teva Pharmaceuticals, Mylan Pharmaceuticals, Inc., Kowa Pharmaceuticals America, Inc., Glenmark Pharmaceuticals Ltd., Sun Pharmaceuticals Industries Ltd. and Wockhardt Limited. A detailed coverage on these market players with information on their revenue from lipid disorder treatment business, market share, gross margin and their growth strategies have been provided in the report.

Lipid Disorder Treatment Market Segmentation

Lipid Disorder Treatment market is segmented on the basis of product type, distribution channel, indication and geography. By product type, the market is segmented into atorvastanin, fluvastanin anf many others. On the basis of distribution channel, the market is categorized as retail pharmacies, hospital pharmacies and others. Geographical coverage has been provided for each of the major regions including North America, Europe, Asia-Pacific, South America and Rest of the World.

Lipid Disorder Treatment Market Segmentation

By Product Type
    • Atorvastatin
    • Fluvastatin
    • Rosuvastatin
    • Simvastatin
    • Pravastatin
    • Other

By Distribution Channel
    • Retail Pharmacies
    • Hospital Pharmacies
    • Online Pharmacies

By Indication
    • Familial Combined Hyperlipidemia
    • Familial Defective Apolipoprotein B-100
    • Familial Dysbetalipoproteinemia
    • Familial Hypertriglyceridemia
    • Heterozygous Familial Hypercholesterolemia
    • Other

Lipid Disorder Treatment By geography
    • North America
             o U.S.
             o Canada
             o Mexico
    • Europe
             o U.K.
             o France
             o Germany
             o Italy
             o Spain
             o Rest of Europe
    • Asia-Pacific
             o China
             o Japan
             o India
             o Korea
             o Rest of APAC
    • South America
             o Brazil
             o Rest of South America
    • Rest of the World
             o Middle East
             o Africa

Lipid Disorder Treatment Market Key Players

• Pfizer, Inc.
• Novartis AG
• Astrazeneca Plc.
• Merck & Co.
• Emcure Pharmaceuticals Ltd.
• Ranbaxy Laboratories Ltd.
• Teva Pharmaceuticals
• Mylan Pharmaceuticals, Inc.
• Kowa Pharmaceuticals America, Inc.
• Glenmark Pharmaceuticals Ltd.
• Sun Pharmaceuticals Industries Ltd.
• Wockhardt Limited.

Please fill in the form below to Request for Customized Report
Your personal details are safe and secured with us. Privacy Policy

To request sample copy of this report, please complete the form below verified and secure

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report. This also includes a 30 minute free analyst discussion post report purchase.

Your personal details are safe and secured with us. Privacy Policy

    What Information does this report contain?

    • What was the market size of the Lipid Disorder Treatment Market in 2017 and the expected market size by 2025, along with the growth rate?
    • An in-depth analysis of the current impacting factors, opportunities and challenges/restraints in the market
    • Which are the largest revenue generating products, services or regions and their comparative growth rate?
    • Which technology is in trend and how would it evolve during the forecast period (2017 - 2025)?
    • Which are the leading companies in the Lipid Disorder Treatment Market and their competitive positioning basis their market share, product portfolio, strategic attempts and business focus?

Purchase Options

Offers & Discounts

  • Chapter purchase
  • Historical market data
  • Country level data breakdown
  • Free customization*
  • Discounts for first time
  • Special pricing for
              non-business entities


  • We offer 20% free customization on every purchase.

Get in touch!